PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
AetnaAll Plans · Coverage · Medical Policy · Wound Care, Emergency Medicine, ENT (Ear, Nose & Throat) +9 moreMedium impact

Hyperbaric Oxygen Therapy (HBOT) (CPB 0172, reviewed 2026-04-21)

Effective date
Not stated in the notice
Identified
Aug 18, 2026

Summary

Aetna considers systemic hyperbaric oxygen therapy (HBOT) medically necessary for conditions including acute air or gas embolism, acute carbon monoxide poisoning, acute thermal burns, decompression sickness, gas gangrene, and chronic refractory stage 3 or 4 osteomyelitis, with usual numbers of sessions listed for each. Continued HBOT for wounds is not considered medically necessary if measurable signs of healing have not been demonstrated within any 30-day period of treatment. Aetna considers systemic HBOT experimental, investigational, or unproven for conditions including Alzheimer's disease, autism spectrum disorders, traumatic brain injury, and COVID-19, and considers topical HBOT and vaporous hyperoxia therapy for non-healing diabetic foot wounds experimental, investigational, or unproven.

Get alerts when payers change rules like this one

We check Aetna and other payers every day and email you when a change matches your specialty and state.

Get Aetna alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01Claims for systemic HBOT under HCPCS G0277 (per 30 minute interval) and physician attendance and supervision under CPT 99183 (per session) need the selection criteria in the policy met.
02Wounds need photographic documentation with a ruler after every 15 treatments and/or at least every 30 days during HBOT, and continued treatment is not considered medically necessary if measurable signs of healing have not been demonstrated within any 30 day period.
03For compromised skin grafts and flaps, the required documentation includes a photograph with a ruler of the graft or flap, the type of flap, the name of the surgeon performing the graft or flap, and whether there was surgical exploration.
04HCPCS A4575 (topical hyperbaric oxygen chamber, disposable) and E0446 (topical oxygen delivery system) are listed as not covered.
05Systemic HBOT is considered experimental, investigational, or unproven and not medically necessary for members with concurrent administration of doxorubicin, cisplatin, or disulfiram, for premature infants (birth prior to 37 weeks gestation), and for untreated pneumothorax.

Codes mentioned

99183G0277A4575E0446A41.4A48.0M72.6N30.41K62.7T70.3XXA

Original notice

Hyperbaric Oxygen Therapy (HBOT) (CPB 0172, reviewed 2026-04-21)
aetna.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account